Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 67,437 | 62,353 | 60,525 | 55,293 | 48,768 |
| Cost of Goods | 8,399 | 6,676 | 6,552 | 6,945 | 5,596 |
| Gross Profit | 59,038 | 55,677 | 53,973 | 48,348 | 43,172 |
| Operating Expenses | 112,198 | 107,698 | 132,582 | 138,316 | 101,073 |
| Operating Income | -52,761 | -51,345 | -78,057 | -89,023 | -57,305 |
| Interest Expense | 6,784 | 3,635 | 3,729 | 3,767 | 4,026 |
| Other Income | -3,739 | 6,191 | -6,801 | 2,905 | -729 |
| Pre-tax Income | -63,284 | -48,789 | -88,587 | -89,885 | -62,060 |
| Income Tax | 727 | 3,703 | 361 | -156 | -251 |
| Net Income Continuous | -64,011 | -52,492 | -88,948 | -89,729 | -61,809 |
| Net Income | $-64,011 | $-52,492 | $-88,948 | $-89,729 | $-61,809 |
| EPS Basic Total Ops | -0.25 | -0.20 | -0.35 | -0.32 | -0.24 |
| EPS Basic Continuous Ops | -0.25 | -0.20 | -0.35 | -0.32 | -0.24 |
| EPS Diluted Total Ops | -0.25 | -0.20 | -0.35 | -0.32 | -0.24 |
| EPS Diluted Continuous Ops | -0.25 | -0.20 | -0.35 | -0.32 | -0.24 |
| EBITDA(a) | $-49,673 | $-49,005 | $-76,062 | $-87,253 | $-56,003 |